| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Cylindrospermopsin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00905
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Cyanotoxin |
| DME Modulation |
Cylindrospermopsin inhibits the expression of DME GSTA2 |
[1] |
| Azaspiracid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01502
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Marine Algal Toxin |
| DME Modulation |
Azaspiracid inhibits the expression of DME GSTA2 |
[2] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Benzo(a)pyrene inhibits the expression of DME GSTA2 |
[3] |
| Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen-mycotoxin |
| DME Modulation |
Aflatoxin B1 inhibits the expression of DME GSTA2 |
[4], [5] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Iprodione |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00851
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health and Environmental Toxicant |
| DME Modulation |
Iprodione up-regulates the expression of DME GSTA2 |
[6] |
| Butyraldehyde |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00999
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Butyraldehyde inhibits the expression of DME GSTA2 |
[7] |
| Diethylhexyl phthalate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01004
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Diethylhexyl phthalate up-regulates the expression of DME GSTA2 |
[8] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Bilirubin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00877
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Bilirubin up-regulates the expression of DME GSTA2 |
[9] |
| Indolo(3,2-B)carbazole |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01343
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Indolo(3,2-B)carbazole inhibits the expression of DME GSTA2 |
[3] |
| Isoimperatorin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01554
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Isoimperatorin up-regulates the expression of DME GSTA2 |
[10] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
| Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate inhibits the expression of DME GSTA2 |
[11] |
| Ketoconazole |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00251
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Ketoconazole inhibits the expression of DME GSTA2 |
[12] |
| Leflunomide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00053
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Leflunomide inhibits the expression of DME GSTA2 |
[13] |
| Phenobarbital |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00410
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Phenobarbital inhibits the drug-metabolizing activity of DME GSTA2 |
[14] |
| Urethane |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00435
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Urethane inhibits the expression of DME GSTA2 |
[15] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Diethyltoluamide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00582
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Diethyltoluamide up-regulates the expression of DME GSTA2 |
[16] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Lactacystin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01362
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2/3 |
| DME Modulation |
Lactacystin up-regulates the expression of DME GSTA2 |
[17] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| K-7174 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
K-7174 inhibits the expression of DME GSTA2 |
[18] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| MG-132 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01219
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
MG-132 up-regulates the expression of DME GSTA2 |
[17] |
|
|
|
|
|
|